Clinical studies have demonstrated that higher GPD1L expression in HCC is associated with an advanced tumour stage, larger tumour size, increased microvascular invasion, and reduced overall and disease-free survival rates [4,5,6,7,8,9,10,20]. The gene discussed is GPD1L; the disease is neoplasm.